Subscribe To
Sales of intravenous iron drugs market is estimated to hit us$ 6.3 bn at a cagr of 8.5% by year 2032-end | future market insights, inc.
Ferric Carboxymaltose to Generate nearly 50% of the intravenous Iron Drugs Market throughout the Analys...
December 8, 2022, 2:30 am
Provention bio gets fda approval for treatment that can delay onset of type 1 diabetes
Shares of Provention Bio Inc. PRVB, -1.09% were down 3.9% in trading on Friday morning, the day after the Food and Drug Administration approved the co...
November 18, 2022, 11:36 am
Victory square technologies subsidiary vs digital health launches the dripbar on apple and google app stores
Victory Square Technologies Inc (CSE:VST, OTCQX:VSQTF) has announced that its white labeled software technology platform from subsidiary VS Digital H...
August 9, 2022, 9:21 am
Braxia scientific expands canadian mental health clinic footprint with newest location in ontario's kitchener-waterloo region
Braxia Scientific Corp has announced the opening of its newest Braxia Health clinic in the Kitchener-Waterloo area in Ontario, its fifth locatio...
June 15, 2022, 9:20 am
Fda gives green signal to human trial for sorrento's sti-9167 against omicron
The FDA has cleared Sorrento Therapeutics Inc's (NASDAQ: SRNE) investigational new drug application (IND) for ...
April 25, 2022, 4:15 pm
Roche (rhhby) actemra application receives priority review
Roche (RHHBY) sBLA is seeking approval for the intravenous formulation of arthritis drug Actemra accept...
April 5, 2022, 1:33 pm
Capricor shares fall after topline results from mid-stage covid-19 trial
Capricor Therapeutics Inc (NASDAQ: CAPR) announced topline data from its Phase 2 INSPIRE study evaluating a single-dose ...
March 28, 2022, 12:22 pm
Argenx's subcutaneous efgartigimod at par with intravenous administration in neuromuscular disorder
Argenx SE (NASDAQ: ARGX) ) has announced topline data from the Phase 3 ADAPT-SC study evaluating subcutaneous (SC) efgartigimod for generalized mya...
March 22, 2022, 12:30 pm
Biogen to present new research at the international conference on alzheimer's and parkinson's diseases (ad/pd 2022)
CAMBRIDGE, Mass., March 11, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the company will present new Alzheimer's disease research, ...
March 11, 2022, 4:30 pm
Wellbeing digital sciences delivers first iv ketamine treatment under new in-patient program
Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc, formerly known as Ketamine One, has announced the successful facilitation of its first
February 15, 2022, 7:36 am
Wellbeing digital sciences delivers first iv ketamine treatment under new in-patient program
Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc, formerly known as Ketamine One, has announced the successful facilitation of its first
February 15, 2022, 7:36 am
Wellbeing digital sciences delivers first iv ketamine treatment under new in-patient program
Wellbeing Digital Sciences (NEO:MEDI.AQN, OTCQB:KONEF) Inc, formerly known as Ketamine One, has announced the successful facilitation of its first
February 15, 2022, 7:36 am